finance

Latest news and updates from Finance.

Sun Pharma registers adjusted net profit of Rs 3219.6 Cr in Q3FY25
Corporate
February 3, 2025

Sun Pharma registers adjusted net profit of Rs 3219.6 Cr in Q3FY25

Q3 Gross Sales at Rs 134,369 million up 10.5 per cent YoY Sun Pharmaceutical Industries reported financials for the third quarter ending December 31, 2024. Highlights of Q3FY25 consolidated financials* ·         Gross sales at Rs 134,369 million, growth of 10.5 per cent ·         India formulation sales at Rs 43,004 million, up 13.8 per cent ·         US formulation sales at $474 million, down 0.7 […]
Article by: IMT News Desk
Aster DM Healthcare registers Rs 3138 Cr revenue in 9M FY25
Finance
February 3, 2025

Aster DM Healthcare registers Rs 3138 Cr revenue in 9M FY25

In 9M FY25, the operating EBITDA was up 35 per cent YoY to Rs 613 crores Aster DM Healthcare announced its financial results for the quarter ended December 31, 2024. Key Financial Highlights Revenue ·       Revenue grew 15 per cent YoY to Rs 3,138 crores in 9M FY25 Vs. Rs 2,721 crores in 9M FY24. ·       Revenue […]
Article by: IMT News Desk
Ayushman Yojana results in significant reduction of out-of-pocket expenditure: Economic Survey
Finance
January 31, 2025

Ayushman Yojana results in significant reduction of out-of-pocket expenditure: Economic Survey

Over Rs 1.25 lakh crore savings recorded The Economic Survey 2024-25 tabled in Parliament today talked about government initiatives, including preventive measures, universal access to high-quality healthcare, strengthened public health infrastructure, and advancements in medical education, which have collectively contributed to making healthcare in India more accessible and affordable for all. As per the Economic […]
Article by: IMT News Desk
Hester Biosciences posts net profit of Rs 11.41 Cr in Q3FY25
Corporate
January 31, 2025

Hester Biosciences posts net profit of Rs 11.41 Cr in Q3FY25

 In 9M FY25 the net profit has been up 85 per cent Y-o-Y to Rs 27.29 crore Ahmedabad-based Hester Biosciences has reported a consolidated net profit of Rs 11.41 crore in Q3FY25 ended December 2024 as against a net profit of Rs 4.02 crore in Q3FY24, a growth of 184 per cent. The company reported […]
Article by: IMT News Desk
OneSource Specialty Pharma posts Rs 3,926 M revenues in Q3FY25
Corporate
January 29, 2025

OneSource Specialty Pharma posts Rs 3,926 M revenues in Q3FY25

EBITDA grew 85 per cent QoQ to Rs 1,432 million OneSource Specialty Pharma announced the consolidated financial results for the quarter (Q3FY25) ended December 31, 2024. Q3FY25 Performance Highlights ·         Revenues of Rs 3,926 million grew 18 per cent QoQ. ·         EBITDA grew 85 per cent QoQ to Rs 1,432 million. ·         EBITDA margin of 36.5 per cent […]
Article by: IMT News Desk
InvAscent invests Rs 1,100 M in Geri Care Health Services
Finance
January 28, 2025

InvAscent invests Rs 1,100 M in Geri Care Health Services

Geri Care intends to utilise the funds to expand its services across key cities in Southern India, including Bengaluru, Hyderabad, Kochi and Coimbatore Healthcare and life sciences-focused private equity investor, InvAscent, through India Life Sciences Fund IV (ILSF IV), has invested Rs 1,100 million in Geri Care Health Services, India’s first integrated senior citizen-focused healthcare […]
Article by: IMT News Desk
India’s health aspirations fall short: The elusive 2.5 per cent GDP spending target
Finance
January 27, 2025

India’s health aspirations fall short: The elusive 2.5 per cent GDP spending target

By Varshith SV India’s healthcare industry, currently valued at approximately $372 billion, is projected to grow to nearly double to over $638 billion by 2030, driven by advancements in medical technology, increased public awareness, and government initiatives like Ayushman Bharat.  Yet, the country faces a daunting challenge: bridging the gap between its potential and the […]
Article by: IMT News Desk
Granules registers decline in revenue from operations for Q3FY25
Corporate
January 24, 2025

Granules registers decline in revenue from operations for Q3FY25

Granules India, announced its financial results for the quarter ended December 31, 2024. Revenue from operations of Q3FY25 stood at Rs 11,377 million, a decline of 2 per cent YoY. Revenue share from North America increased to 77 per cent in Q3 FY25, compared to 66 per cent in Q3 FY24. Finished dosages (FD), Active […]
Article by: IMT News Desk
Mankind Pharma posts Rs 3230 Cr revenue in Q3 FY25
Corporate
January 24, 2025

Mankind Pharma posts Rs 3230 Cr revenue in Q3 FY25

The 9M FY25 registers Rs 9200 crore revenue Mankind Pharma announced its financial results for the third quarter and nine months ended December 31, 2024. The information mentioned in this release is based on consolidated financial statements. Rajeev Juneja – Vice Chairman and Managing Director, Mankind Pharma said, “We achieved a healthy revenue growth of […]
Article by: IMT News Desk
Senores Pharma registers Rs 288 Cr revenue in 9MFY25
Corporate
January 23, 2025

Senores Pharma registers Rs 288 Cr revenue in 9MFY25

The company posted an EBITDA of Rs 74 crore which is 287 per cent increase Ahmedabad-based Senores Pharmaceuticals has reported revenue of Rs 288 crore during 9MFY25 ending December 31, 2024, reflecting a robust growth of 157 per cent. The exceptional financial performance underscores the company’s strong business strategies and operational excellence. Key highlights Swapnil […]
Article by: IMT News Desk